211 related articles for article (PubMed ID: 8585741)
1. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms.
Lauterwein M; Oethinger M; Belsner K; Peters T; Marre R
Antimicrob Agents Chemother; 1995 Nov; 39(11):2541-3. PubMed ID: 8585741
[TBL] [Abstract][Full Text] [Related]
2. Induction of murine cytochrome P4503A by the lichen constituents usnic and vulpinic acids.
Mannering GJ; Shoeman JA
Drug Metab Dispos; 1994; 22(4):663-5. PubMed ID: 7956745
[No Abstract] [Full Text] [Related]
3. In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria.
Yong D; Yum JH; Lee K; Chong Y; Choi SH; Rhee JK
Antimicrob Agents Chemother; 2004 Jan; 48(1):352-7. PubMed ID: 14693566
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic and antiproliferative properties of the lichen substances (-)-usnic acid and vulpinic acid.
Koparal AT
Z Naturforsch C J Biosci; 2015; 70(5-6):159-64. PubMed ID: 26136299
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic properties of lichen secondary metabolites.
Ulus G
Phytother Res; 2021 Jun; 35(6):3046-3058. PubMed ID: 33587324
[TBL] [Abstract][Full Text] [Related]
6. Specialized Metabolites of the Lichen Vulpicida pinastri Act as Photoprotective Agents.
Legouin B; Lohézic-Le Dévéhat F; Ferron S; Rouaud I; Le Pogam P; Cornevin L; Bertrand M; Boustie J
Molecules; 2017 Jul; 22(7):. PubMed ID: 28704942
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients.
Pompilio A; Pomponio S; Di Vincenzo V; Crocetta V; Nicoletti M; Piovano M; Garbarino JA; Di Bonaventura G
Future Microbiol; 2013 Feb; 8(2):281-92. PubMed ID: 23374132
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents.
Yilmaz M; Türk AO; Tay T; Kivanç M
Z Naturforsch C J Biosci; 2004; 59(3-4):249-54. PubMed ID: 15241936
[TBL] [Abstract][Full Text] [Related]
12. Study of fungal and bacterial infections of the diabetic foot.
Chincholikar DA; Pal RB
Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
[TBL] [Abstract][Full Text] [Related]
13. Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Elo H; Matikainen J; Pelttari E
Naturwissenschaften; 2007 Jun; 94(6):465-8. PubMed ID: 17245580
[TBL] [Abstract][Full Text] [Related]
14. Letharia vulpina, a vulpinic acid containing lichen, targets cell membrane and cell division processes in methicillin-resistant Staphylococcus aureus.
Shrestha G; Thompson A; Robison R; St Clair LL
Pharm Biol; 2016; 54(3):413-8. PubMed ID: 25919857
[TBL] [Abstract][Full Text] [Related]
15. The activity of metal compounds against aerobic and anaerobic bacteria.
Chin N; Neu HC
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):549-52. PubMed ID: 1424509
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds.
Burlando B; Ranzato E; Volante A; Appendino G; Pollastro F; Verotta L
Planta Med; 2009 May; 75(6):607-13. PubMed ID: 19199230
[TBL] [Abstract][Full Text] [Related]
17. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces.
Francolini I; Norris P; Piozzi A; Donelli G; Stoodley P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4360-5. PubMed ID: 15504865
[TBL] [Abstract][Full Text] [Related]
18. Determination of usnic acid in some Rhizoplaca species from Middle Anatolia and their antimicrobial activities.
Cansaran D; Cetin D; Halici MG; Atakol O
Z Naturforsch C J Biosci; 2006; 61(1-2):47-51. PubMed ID: 16610216
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antimicrobial activity of the acetone extract of the lichen Ramalina farinacea and its (+)-usnic acid, norstictic acid, and protocetraric acid constituents.
Tay T; Türk AO; Yilmaz M; Türk H; Kivanç M
Z Naturforsch C J Biosci; 2004; 59(5-6):384-8. PubMed ID: 18998406
[TBL] [Abstract][Full Text] [Related]
20. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
